80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]張秀安.非基因重組促細(xì)胞生成素依賴的血液透析影響因素分析[J].福建醫(yī)藥雜志,2022,44(05):18-21.
　ZHANG Xiu'an.Analysis of influencing factors of non-gene recombinant erythropoietin-dependent hemodialysis[J].FUJIAN MEDICAL JOURNAL,2022,44(05):18-21.
點(diǎn)擊復(fù)制

非基因重組促細(xì)胞生成素依賴的血液透析影響因素分析()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
44
期數(shù):
2022年05期
頁碼:
18-21
欄目:
臨床研究
出版日期:
2022-10-15

文章信息/Info

Title:
Analysis of influencing factors of non-gene recombinant erythropoietin-dependent hemodialysis
文章編號:
1002-2600（2022）05-0018-04
作者:
張秀安
福建醫(yī)科大學(xué)附屬漳州市醫(yī)院腎內(nèi)科（漳州 363000）
Author(s):
ZHANG Xiu'an
Department of Nephrology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian 363000, China
關(guān)鍵詞:
血液透析; 貧血
Keywords:
hemodialysis;  anemia
分類號:
R692.5
文獻(xiàn)標(biāo)志碼:
B
摘要:
目的 探討非基因重組促紅細(xì)胞生成素（r-HuEPO）依賴的血液透析的發(fā)病情況及影響因素。 方法 回顧性分析2017年8月1日至2020年7月31日在漳州市醫(yī)院接受維持性血液透析治療患者的臨床資料，調(diào)查非r-HuEPO依賴的血液透析的發(fā)病情況及可能的影響因素。 結(jié)果 375例維持性血液透析患者中，非r-HuEPO依賴的透析發(fā)病率僅為6.4%。合并多囊腎病5例，獲得性腎囊腫14例，單純腎囊腫4例，惡性腫瘤1例。未發(fā)現(xiàn)乙型肝炎病毒感染與非r-HuEPO依賴的透析相關(guān)。多因素回歸模型結(jié)果提示，性別和透析齡為非r-HuEPO依賴的透析發(fā)病的影響因素。 結(jié)論 非r-HuEPO依賴的透析發(fā)病率不高，囊腫性腎臟疾病可能是其潛在的病因，未發(fā)現(xiàn)乙型肝炎病毒感染與非r-HuEPO依賴的關(guān)聯(lián)性。性別和透析齡為非r-HuEPO依賴的透析發(fā)病的影響因素。
Abstract:
Objective To investigate the incidence and influencing factors of non-gene recombinant erythropoietin (r-HuEPO)-dependent hemodialysis. Methods The clinical data of patients receiving maintenance hemodialysis in Zhangzhou Hospital from August 1, 2017 to July 31, 2020 were retrospectively analyzed to investigate the incidence of non-r-HuEPO-dependent hemodialysis and possible related factors.Results Among 375 MHD patients, the incidence of non- r-HuEPO-dependent dialysis was 6.4%. There were 5 cases of polycystic kidney disease, 14 cases of acquired Cystic kidney disease, 4 cases of simple Cystic kidney disease, and 1 case of malignant tumor. Hepatitis B virus infection was not associated with non- r-HuEPO-dependent dialysis. Gender and dialysis vintage might be the risk factors for the onset of non-r-HuEPO-dependent dialysis. Conclusion The incidence of non- r-HuEPO-dependent dialysis is low.Cystic kidney disease may be the potential cause of non- r-HuEPO-dependent dialysis. We do not find that hepatitis B virus infection is associated with non- r-HuEPO-dependent dialysis. Gender and dialysis vintage might be the risk factors for the onset of non- r-HuEPO-dependent dialysis.

參考文獻(xiàn)/References:

[1] Fishbane S, Spinowitz B.Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018[J].Am J Kidney Dis，2018，71(3):423-435.
[2] Hasegawa T, Koiwa F, Akizawa T.Anemia in conventional hemodialysis: Finding the optimal treatment balance[J].Seminars in Dialysis，2018，31(6):599-606.
[3] Kuo C C, Lee C T, Chung C H, et al.Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis[J].Clin Nephrol，2005，63(2):92-97.
[4] Wan Q J, He Y C, Zhang W F, et al.Prevalence and related factors of the absence of anemia among Chinese chronic hemodialysis patients: a multicenter cross-sectional study[J].Int Urol Nephrol，2014，46 (8)：1651-1654.
[5] Verdalles U, Abad S, Vega A, et al.Factors related to the absence of anemia in hemodialysis patients[J].Blood Purif,2011,32(1):69-74.
[6] Sheqwara J, Alkhatib Y, Dabak V, et al.Idiopathic Erythrocytosis in Dialysis Patients: A Case Report and Literature Review[J].Am J Nephrol, 2013,37(4):333-338.
[7] Pisoni R L, Bragg-Gresham J L, Young E W, et al.Anemia management and outcomes from 12 countries in the dialysis and practice patterns study (DOPPS[BF])[BFQ][J].Am J Kidney Dis，2004,44(1):94-111.
[8] Shih H M, Wu C J, Lin S L.Physiology and pathophysiology of renal erythropoietin-producing cells[J].J Formos Med Assoc，2018,117(11):955-963.
[9] Kobayashi H, Davidoff O, Pujari-Palmer S, et al.EPO synthesis induced by HIF-PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non-injured nephron segments in murine kidney fibrosis[J].Acta Physiol (Oxf), 2022，235(4):e13826.
[10] Palop L.Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin[J].Am J Nephrol，1991,11:12-15.
[11] Lnnberg M, Garle M, Lnnberg L, et al.Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis[J].J Pharm Biomed Anal，2013,81-82: 187-192.
[12] de Seigneux S, Lundby A-K M，Berchtold L, et al.Increased synthesis of liver erythropoietin with CKD[J].J Am Soc Nephrol，2016, 27(8): 2265-2269.
[13] Annese T, Tamma R, Ruggieri S, et al.Erythropoietin in tumor angiogenesis[J].Exp Cell Res, 2019,15,374(2):266-273.
[14] Shirazian S, Starakiewicz P, Latcha S.Cancer Screening in End-Stage Kidney Disease[J].Adv Chronic Kidney Dis, 2021,28(5):502-508.
[15] Goembiewska E, Ciechanowski K.Repeat exit site infection in peritoneal dialysis patient with polycythemia vera- a case report[J].BMC Infect Dis,2021, 21(1):624.
[16] lger Y, Delik A.Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients[J].Eur J Gastroenterol Hepatol, 2022, 34(7):769-773.
[17] Fox S, Griffin L, Robinson H D.Polycythemia Vera: Rapid Evidence Review[J].Am Fam Physician, 2021,103(11):680-687.

相似文獻(xiàn)/References:

[1]王明哲,陳 堅(jiān),楊 楓.有中心靜脈置管史的血透患者再置管的臨床分析(附17例報(bào)告)[J].福建醫(yī)藥雜志,2021,43(02):130.

更新日期/Last Update: 2022-10-15